Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.

The purpose of this study was to develop and characterize a novel fluorescence-based retention assay for the evaluation of the release profile of bone morphogenetic protein-2 (BMP-2) released from bone graft carrier. In this study, we evaluated the binding, release kinetics, and delivery efficacies...

Full description

Bibliographic Details
Main Authors: Wonmo Kang, Dong-Sung Lee, Jun-Hyeog Jang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0123402
id doaj-6e59a8d4d3b0450b9977397afc97306b
record_format Article
spelling doaj-6e59a8d4d3b0450b9977397afc97306b2021-03-03T20:06:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012340210.1371/journal.pone.0123402Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.Wonmo KangDong-Sung LeeJun-Hyeog JangThe purpose of this study was to develop and characterize a novel fluorescence-based retention assay for the evaluation of the release profile of bone morphogenetic protein-2 (BMP-2) released from bone graft carrier. In this study, we evaluated the binding, release kinetics, and delivery efficacies of BMP-2 incorporated into hydroxyapatite (HA) bone grafts. The evaluation of the release profile of BMP-2 from HA bone grafts using a fluorescence-based retention assay revealed initial burst releases from the HA bone grafts followed by long sustained releases up to 14 weeks. The sustained biological activity of the released BMP-2 from HA bone grafts over the full 14-week period supports a long sustained mechanism via fluorescence-based retention assay. Thus, the results from this study show that BMP-2 could be incorporated into HA bone grafts for sustained release over a prolonged period of time with retention of bioactivity and our fluorescence-based retention assay, which is principally detecting the retention profile of BMP-2 in HA bone grafts, is more accurate than conventionally collecting the released BMP-2 for evaluation of BMP-2 release profiles.https://doi.org/10.1371/journal.pone.0123402
collection DOAJ
language English
format Article
sources DOAJ
author Wonmo Kang
Dong-Sung Lee
Jun-Hyeog Jang
spellingShingle Wonmo Kang
Dong-Sung Lee
Jun-Hyeog Jang
Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
PLoS ONE
author_facet Wonmo Kang
Dong-Sung Lee
Jun-Hyeog Jang
author_sort Wonmo Kang
title Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
title_short Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
title_full Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
title_fullStr Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
title_full_unstemmed Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay.
title_sort evaluation of sustained bmp-2 release profiles using a novel fluorescence-based retention assay.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description The purpose of this study was to develop and characterize a novel fluorescence-based retention assay for the evaluation of the release profile of bone morphogenetic protein-2 (BMP-2) released from bone graft carrier. In this study, we evaluated the binding, release kinetics, and delivery efficacies of BMP-2 incorporated into hydroxyapatite (HA) bone grafts. The evaluation of the release profile of BMP-2 from HA bone grafts using a fluorescence-based retention assay revealed initial burst releases from the HA bone grafts followed by long sustained releases up to 14 weeks. The sustained biological activity of the released BMP-2 from HA bone grafts over the full 14-week period supports a long sustained mechanism via fluorescence-based retention assay. Thus, the results from this study show that BMP-2 could be incorporated into HA bone grafts for sustained release over a prolonged period of time with retention of bioactivity and our fluorescence-based retention assay, which is principally detecting the retention profile of BMP-2 in HA bone grafts, is more accurate than conventionally collecting the released BMP-2 for evaluation of BMP-2 release profiles.
url https://doi.org/10.1371/journal.pone.0123402
work_keys_str_mv AT wonmokang evaluationofsustainedbmp2releaseprofilesusinganovelfluorescencebasedretentionassay
AT dongsunglee evaluationofsustainedbmp2releaseprofilesusinganovelfluorescencebasedretentionassay
AT junhyeogjang evaluationofsustainedbmp2releaseprofilesusinganovelfluorescencebasedretentionassay
_version_ 1714824086090153984